Ultivue nets $20 mln Series B
Cambridge, Massachusetts-based Ultivue, a developer of reagent-driven solutions for high-performance biological imaging in situ, has raised $20 million in Series B funding round. ARCH Venture Partners led the round.
23 January 2018•1 min read
